Biotechnology

Bristol-Myers Squibb swings to profit in Q1 2025; revenue drops

April 24, 2025

MRK Earnings: Merck & Co. Q1 adj. profit rises, beats estimates

April 24, 2025

Earnings: Intuitive Surgical (ISRG) reports higher revenue and profit for Q1 2025

April 23, 2025

Abbott Laboratories (ABT) Q1 2025 Earnings: Key financials and quarterly highlights

April 16, 2025

OS Therapies is actively advancing its osteosarcoma immunotherapy: CEO Paul Romness

March 25, 2025

Illumina (ILMN) expects adjusted EPS of approximately $4.50 for FY25

March 11, 2025

Earnings Summary: Moderna slips to loss in Q4; revenue down 66%

February 17, 2025

Key metrics from Biogen’s (BIIB) Q4 2024 earnings results

February 12, 2025

Highlights of Bristol-Myers Squibb’s Q4 2024 earnings report

February 6, 2025

LLY Earnings: Eli Lilly Q4 2024 profit more than doubles; revenue up 45%

February 6, 2025

MRK Earnings: Merck Q4 2024 adj. profit jumps on strong sales growth

February 4, 2025

AbbVie Q4 2024 adjusted earnings decline despite 6% revenue growth

January 31, 2025

Earnings Summary: DexCom reports preliminary Q4 2024 results

January 14, 2025

NeOnc Technologies plans to go public through direct listing

January 7, 2025

Walgreens Boots Alliance expected to report mixed Q1 2025 results

January 2, 2025

“Gelteq has been continuously evolving to expand applications and audiences”

December 18, 2024

Pfizer (PFE) reaffirms FY24 forecast; provides FY25 guidance

December 17, 2024

Earnings Summary: A snapshot of CooperCompanies (COO) Q4 2024 results

December 6, 2024

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

November 22, 2024

Earnings Summary: Moderna swings to profit in Q3 on modest revenue growth

November 7, 2024

Key metrics from Bristol Myers Squibb’s (BMY) Q3 2024 earnings results

October 31, 2024